Suchergebnisse - "Allegretti, Jessica R"

PubPharm (24)

1

Risk of Gastrointestinal Infections After Initiating Vedolizumab and Anti-TNFα Agents for Ulcerative Colitis

enthalten in: Journal of clinical gastroenterology | 2023

von Dalal, R. | Mitri, J. | Goodrick, H. | +1

2

Low-Dose Interleukin 2 for the Treatment of Moderate to Severe Ulcerative Colitis

enthalten in: Gastroenterology | 2023

von Allegretti, J. | Mitsialis, V. | Canavan, J. | +30

3

Prevalence of Clostridioides difficile Infection After Ileal Pouch-anal Anastomosis in Patients With Chronic Antibiotic-dependent Pouchitis and Crohn's-like Disease of the Pouch

enthalten in: Inflammatory bowel diseases | 2023

von Shore, B. | Weaver, K. | Allegretti, J. | +2

4

Long-Term Outcomes After Ustekinumab Dose Intensification for Inflammatory Bowel Diseases

enthalten in: Inflammatory bowel diseases | 2023

von Dalal, R. | Pruce, J. | Allegretti, J.

5

Comparative Long-Term Drug Survival of Vedolizumab, Adalimumab, and Infliximab in Biologic-Naïve Patients with Ulcerative Colitis

enthalten in: Digestive diseases and sciences | 2023

von Dalal, R. | McClure, E. | Marcus, J. | +1

6

Predictors and Outcomes of Ustekinumab Dose Intensification in Ulcerative Colitis : A Multicenter Cohort Study

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Dalal, R. | Esckilsen, S. | Barnes, E. | +3

7

Mimics of Crohn's Disease

enthalten in: Gastroenterology clinics of North America | 2022

von Gupta, S. | Allegretti, J.

8

Gut metabolites predict Clostridioides difficile recurrence

enthalten in: Microbiome | 2022

von Dawkins, J. | Allegretti, J. | Gibson, T. | +4

9

Fecal Microbiota Transplantation for Chronic Pouchitis : Promising Novel Therapeutic or Lost Cause?

enthalten in: Inflammatory bowel diseases | 2021

von Dalal, R. | Allegretti, J.

CommentIn: Inflamm Bowel Dis. 2021 Jun 15;27(7):e79-e80. - PMID 33501940

10

Real-World Comparison of Tofacitinib vs Ustekinumab Among Bio-Exposed Patients With Ulcerative Colitis : A Propensity Score Analysis

enthalten in: Inflammatory bowel diseases | 2021

von Dalal, R. | Mitri, J. | Goodrick, H. | +1